François Blondel
Chairman of the Board
Mr François Blondel is the Chairman of the Board of Directors and Managing Director of the company.

Having graduated in both Law and Science Economics, he nowadays combines executive functions (as CEO of KitoZyme) with non-executive board memberships, either as Chairman of the Board or as an independent Board member. The companies in which he is - or has been - active range from SME’s, spin-offs and Research centers, such as OncoDNA, NANOCYL (a world leader in production of carbon nanotubes), Delphi Genetics, KiOmed Pharma, etc. which are active in the technology, medical or healthcare sectors to major listed companies, such as RECTICEL (industrial multinational group - Euronext) or Compagnie du BOIS SAUVAGE (diversified holding – Euronext) and public authorities, such as AWEX (export agency for the Walloon Region), AMONIS (largest pension fund for MD's in Belgium) and BioWIN. As an entrepreneur, he has (co)founded several start-ups and gained broad experience in the management of innovation driven companies. He started his career in the chemical sector and undertook assignments both in the United States and in Europe. In 1999, he joined International Brachytherapy (IBt), a medical device startup that focused on cancer treatment. He served as CEO, leading IBt, a Euronext stock listed company, from its R&D stage to a successful and well-diversified international group that became a European leader in its market segment.

Cédric Szpirer
Executive & Scientific Director
Cédric Szpirer is Engineer in agronomy and obtained his PhD in molecular biology from Université Libre de Bruxelles in 2000. He founded Delphi Genetics in 2001 with two colleagues when he was Research associate at University of Brussels (laboratory of genetic evolution). He joined the company as first employee in 2004. He was firstly Head of research & development and in 2010, he combined this position with the executive direction of the company. He is now Executive & Scientific director of Delphi Genetics. He is also member of the board of Immunehealth. He is inventor or co-inventor of more than 10 patents families (issued and pending) in the field of molecular biology and more precisely in recombinant productions and DNA engineering. He was also involved in patent licensing & acquisition.



Cédric Volanti
Cédric serves as COO of Delphi genetics since July 2017. Cédric holds a PhD in Molecular and Cellular Biology complemented with a Master degree in Management. Beside its strong academic background at the University of Liège (Belgium) and Harvard University (USA), Cédric has an impressive track record in the Biopharmaceutical and Biotechnology industries. First with SGS where he was in charge of the General Management and Board Member of SGS Lab Simon S.A in Belgium and later Global Business Development Manager Biologics for the Life Sciences Services division of the group in Switzerland, reporting directly to the EVP.  He then joined PharmaCell B.V. in the Netherlands, as Head of the QC and PD&R departments. In those positions, Cédric was member of the Management Board and Quality Board of the Company. Lately, Cédric served as Director Life Sciences Products and Services at Eurogentec S.A., in Belgium and was as well member of the Management Committee of the company. In his free time, Cédric is an active climber and alpinist always looking for new exiting adventures and challenges.
Sophie Scohy
Services Director
After a PhD in molecular biology at Université Libre de Bruxelles and a post-doc at Institut Jules Bordet, Sophie Scohy joined Biovallée in 2001 as Research manager to set-up and manage the genetic engineering department. Sophie joined Delphi Genetics in 2005 to manage the genetic engineering services of the company. Since 2012,  she has been Services Director and manages now the service activity of the company.


Thierry Van Reeth
Scientific & Project Manager
After a PhD in molecular Biology, he joined Biovallée in 2002 to set-up and manage the transgenic platform. From this activity, he founded BV transgenic Services where he was in charge of the management and the scientific activity until 2010. During the next 3 years, he was in charge of business development in the scientific recruitment field. He joined then Delphi Genetics in 2013 as Scientific and Sales Manager to develop and promote the service activity of the company. Thierry now offices as Scientific and Project Manager.
Jean Michel Schaus
Business Development Manager
Jean Michel joined Delphi Genetics, as Business Development Manager, in July 2018. With a Master in Molecular Biology from Namur University, Jean Michel developed a deep expertise in Lead Identification and Development of Biologics Drug Candidates (i.e. DNA, Recombinant proteins, antibodies, vaccines) serving at Dyax (now part of Shire), GSK Vaccines, and lately as Business Developer at Kaneka Eurogentec Biologics.